Three approaches to radiolabeling antibodies with 99mTc (original) (raw)

Directly and indirectly technetium-99m-labeled antibodies--a comparison of in vitro and animal in vivo properties

Miklos Fogarasi

PubMed, 1993

View PDFchevron_right

The labeling of high affinity sites of antibodies with 99mTc

Susan Heald

International Journal of Nuclear Medicine and Biology, 1985

View PDFchevron_right

Antibody labeling with radioiodine and radiometals

Maneesh Jain

Methods in molecular biology (Clifton, N.J.), 2014

View PDFchevron_right

Radiopharmaceutical management of90Y/111In labeled antibodies: shielding and quantification during preparation and administration

Formijn Van Hemert

Annals of Nuclear Medicine, 2006

View PDFchevron_right

The Diagnostic Role of Radiolabeled Antibodies

khaled elsaban

2017

View PDFchevron_right

Labeling of monoclonal antibodies with radionuclides

Seetharama Acharya

Seminars in Nuclear Medicine, 1989

View PDFchevron_right

Radiolabeling of Antibodies

William Eckelman

Cancer Research, 1980

View PDFchevron_right

Development of a Model System to Evaluate Methods for Radiolabeling Monoclonal Antibodies

Robert Nicolotti

Journal of Nuclear Medicine, 1984

View PDFchevron_right

Methods for Radiolabelling of Monoclonal Antibodies

Vladimir Tolmachev

Methods in Molecular Biology, 2013

View PDFchevron_right

Direct labeling of monoclonal antibodies with 99mTc and radioimmunodetection of a murine mammary carcinoma with 99mTc-B2C114

Alberto Horenstein

Journal of nuclear biology and medicine (Turin, Italy: 1991)

View PDFchevron_right

In Vivo and In Vitro Characterizations of Three 99mTc-Labeled Monoclonal Antibody G250 Preparations

Otto Boerman, Egbert Oosterwijk

2000

View PDFchevron_right

Technetium-99m-labeled monoclonal antibodies for immunoscintigraphy:: Simplified preparation and evaluation

Mukesh Thakur

Journal of immunological methods, 1991

View PDFchevron_right

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

Frank Cuttitta

Journal of Immunological Methods, 1984

View PDFchevron_right

[Radiolabeled antibodies for cancer treatment]

Jacques Barbet

Médecine sciences : M/S, 2009

View PDFchevron_right

Iodination of monoclonal antibodies for diagnosis and radiotherapy using a convenient one vial method

Hidde Haisma

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1986

View PDFchevron_right

Prevention of radiolysis of monoclonal antibody during labeling

Nhật Long Lê

Journal of Nuclear …, 1996

View PDFchevron_right

Evolution of Tc-99m in diagnostic radiopharmaceuticals

Pillai M.R.A.

View PDFchevron_right

99M-TECHNETIUM Labelling of a Tumor Associated Murine Monoclonal Antibody for Immunoscintigraphic Studies in Man

Alexandra Varvarigou

Journal of Labelled Compounds and Radiopharmaceuticals, 1994

View PDFchevron_right

Human Polyclonal Immunoglobulin Labelled with Technetium-99m via NHS-MAG3: A Comparison of Radiochemical Behavior and Biological Efficacy with Other Labelling Methods

helena gil peña

Nuclear Medicine and Biology, 1998

View PDFchevron_right

Technetium-99m labelling of human immunoglobulin and preliminary clinical evaluation in tumour patients

Alexandra Varvarigou

European Journal of Drug Metabolism and Pharmacokinetics, 1998

View PDFchevron_right

The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody

Paul Boulos

British Journal of Cancer, 1991

View PDFchevron_right

Effects of Radiolabeling Monoclonal Antibodies with a Residualizing Iodine Radiolabel on the Accretion of Radioisotope in Tumors1

Amartya Basu

2000

View PDFchevron_right

RADIATION ABSORBED DOSES AND SAFETY OF THE HUMANIZED MONOCLONAL ANTIBODY HR3 LABELED WITH 99MTC

Normando Iznaga

2001

View PDFchevron_right

Radiopharmaceutical management of Y-90/In111 labeled antibodies: shielding and quantification during preparation and administration

Formijn Van Hemert

2006

View PDFchevron_right

Experimental radioimmunotargeting combining nonlabeled, iodine‐125‐labeled, and anti‐idiotypic anticytokeratin monoclonal antibodies

Rauni Norrlund, Lennart Johansson

Cancer, 1997

View PDFchevron_right

Technetium-99m labeling of murine monoclonal antibody fragments

Edward Antonio Pimentel Valdez

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1986

View PDFchevron_right

Current status of radioimmunodetection

Farhad Daghighian

Nuclear Medicine and Biology, 1994

View PDFchevron_right

Modification of antibody isoelectric point affects biodistribution of 111-indium-labeled antibody

Anthony Petrick

Nuclear Medicine and Biology, 1996

View PDFchevron_right

188ReDirect Labeling of Monoclonal Antibodies for Radioimmunotherapy of Solid Tumors: Biodistribution, Normal Organ Dosimetry, and Toxicology

Normando Iznaga

Nuclear Medicine and Biology, 1998

View PDFchevron_right

Recent developments in monoclonal antibody radiolabeling techniques

Ronnie Mease

OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information), 1989

View PDFchevron_right

Tritium radiolabeling of antibodies to high specific activity with N-succinimidyl[2,3-3H]propionate: Use in detecting monoclonal antibodies

Ilias Doxiadis

Journal of Immunological Methods, 1981

View PDFchevron_right

The development of technetium-99m-labelled interleukin-2: A new radiopharmaceutical for the In vivo detection of mononuclear cell infiltrates in immune-mediated diseases

Alberto Signore

Nuclear Medicine and Biology, 1997

View PDFchevron_right